Wednesday, 20 July 2016

Scientists have discovered never-before-seen vessels in the brain

Source Science Alert:

Scientists in the US have discovered a new series of lymphatic vessels in the body that link the brain to the immune system - a connection researchers had previously thought didn't exist.

The discovery could not only prompt a rewrite of the textbooks, it might also lead to a new understanding of how our immune system influences our brain and our behaviour. Read on.

Is it possible to get stronger just by thinking about exercise?

Source BBC:

Could simply thinking about exercise – without so much as lifting a finger – really do the trick?
It sounds incredibly unlikely, but ‘motor imagery’ is a technique often used by top athletes, and some studies suggest that you can use it to improve your strength by mental training alone.
Trust Me, I’m a Doctor teamed up with The University of Northampton’s Professor Tony Kay to put this wonderfully weird idea to the test  Read on

Finally, Attention Switches To Progressive Multiple Sclerosis.

Source Managed Care Mag.

A surge of new MS treatments have been for the relapsing-remitting form of the disease. A new drug that targets CD20-positive B cells may change that.  Read on.

Panthera Ultralight wheelchair available

"Panthera wheelchair. Ultra lightweight wheelchair with detachable wheels and foldable back. Made from a “chrome-moly” (lightweight steel) frame – only 10.5 kilos. 42 cm seat. Two sets of hand rims – metal or rubber coated. For sale with the proceeds going as a donation to BMSTC". Please email

Effect of cholesterol medicine on inflammatory diseases mapped

Source: Science Daily

The cholesterol medicine simvastatin, which is one of the most commonly used pharmaceuticals in the world, also has a beneficial effect on the immune defense system with regard to diseases such as type 1 diabetes, multiple sclerosis and rheumatoid arthritis. Danish researchers have now explored why this is so, and their findings may result in improved treatment.  Read on.

Thursday, 7 July 2016

Rough Guide to Accessble Britain

Great days out have never been to accessible.  The brand new sixth edition of the Rough Guide to Accessible Britain is now available to view for free via our online reader.  It’s packed with over 200 inspiring ideas for fantastic worry-free days out with reviews, hints and tips on some of the UK’s best attractions written by and for disabled people.  For more click here.

Could the gut microbiome be a new therapeutic target for multiple sclerosis?

Source EurekAlert:

New Rochelle, NY, July 6, 2016--An increasing number of clinical studies are pointing to a link between the autoimmune disease multiple sclerosis (MS) and the composition of microbes in the human gut,  sparking new research on the gut microbiome as a potential target for MS treatment and prevention.  Read on

Siponimod Effective in Reducing Disease Activity in Relapsing=-Remitting MS

Source Neurology Advisor:

Results from the 24-month extension of the phase 2 BOLD study demonstrated no new safety concerns and low disease activity in patients with relapsing-remitting multiple sclerosis (RRMS) treated with siponimod.  Read on.

Newly Approved therapy reduces frequency of Multiple Sclerosis relapses by 54%


Biogen and AbbVie have been granted EU marketing authorization for Zinbryta (daclizumab), to treat adult patients with relapsing forms of multiple sclerosis. Relapse frequency per year was shown to be reduced by up to 45% against other treatments, and 54% against placebo.  Read on.